Brief: Orion Pharma Announces Agreement With Qilu Pharma Europe
06/10/2026 07:03
BRIEF-Orion Pharma Announces Agreement With Qilu Pharma Europe Oct 6 (Reuters) - Orion Oyj ORNBV.HE:
ORION PHARMA ANNOUNCES AGREEMENT WITH QILU PHARMA EUROPE FOR PEMBROLIZUMAB BIOSIMILAR FOR EUROPEAN MARKET
AGREEMENT TO COMMERCIALISE INTRAVENOUS (IV) PEMBROLIZUMAB BIOSIMILAR IN EUROPE
WILL GAIN EXCLUSIVE RIGHT TO DISTRIBUTE, MARKET AND SELL QILU'S IV PEMBROLIZUMAB BIOSIMILAR
Source text: ID:nGNE7s8rGp
Further company coverage: ORNBV.HE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))